BofA analyst Ronald Epstein raised the firm’s price target on Cadre to $38 from $29 and keeps a Buy rating on the shares. The firm continues to see strong global safety demand and now applies the higher multiple to its estimates for Cadre to account for upside from future M&A opportunities.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CDRE:
